Compounds > dronabinol
Page last updated: 2024-08-21

dronabinol and Cytokine Release Syndrome

dronabinol has been researched along with Cytokine Release Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kovalchuk, I; Kovalchuk, O; Pryimak, N; Suryavanshi, SV; Zaiachuk, M1
Bentur, OS; Hochner, O; Ingbir, M; Porat, R; Szekely, Y1

Other Studies

2 other study(ies) available for dronabinol and Cytokine Release Syndrome

ArticleYear
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
    Cells, 2022, 04-20, Volume: 11, Issue:9

    Topics: Cannabidiol; Cannabinoids; COVID-19; Cytokine Release Syndrome; Cytokines; Dronabinol; Humans; Inflammasomes; Lipopolysaccharides; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; STAT3 Transcription Factor; TYK2 Kinase

2022
Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model.
    European cytokine network, 2020, Jun-01, Volume: 31, Issue:2

    Topics: Anti-Inflammatory Agents; Biological Products; Cannabinoids; Cells, Cultured; Cytokine Release Syndrome; Cytokines; Dose-Response Relationship, Drug; Dronabinol; Humans; Inflammation Mediators; Lipopolysaccharides; Sepsis

2020